Business · 03/08/2023Updated: 10/17/2026 · 1 min read
FDA Announces Draft Guidance on Waivers for HIV Antiretroviral Drugs
Summary
The FDA is releasing a draft guidance on when companies can get waivers, reductions, or refunds for certain HIV treatments under the Prescription Drug User Fee Act (PDUFA).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →